Advanced Search


Study ID Status Title Patient Level Data
114055 Active, not recruiting A Multi-center, Randomized, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Patients with Systemic Lupus Erythematosus
115466 Completed A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination with Azathioprine for the Maintenance of Remission in Wegener's Granulomatosis and Microscopic Polyangiitis
115666 Completed MEA115666: A multi-centre, open-label, long term safety study of mepolizumab in asthmatic subjects who participated in the MEA112997 trial
116287 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety of KIVEXA(abacavir/lamivudine) administered in Korean patients according to the prescribing information
116318 Completed Plan for Re-Evaluation of Sudden Unexplained Death in Epilepsy (SUDEP) Occurring in the Lamotrigine Clinical Development Program
116689 Completed An integrated review to evaluate dose response of umeclidinium (GSK573719) administered once or twice daily in Subjects with COPD
116844 Completed Meta-Analysis Results Report for DB2116844: Meta-analysis of DB2113360 and DB2113374: an Integrated Review of Transition Dyspnoea Index data for Umeclidinium/Vilanterol, Umeclidinium, Vilanterol and Tiotropium over 24 Weeks in Subjects with COPD
116963 Completed PGx6304: Detailed evaluation of potential role of genetic variation within GLCCI1 and its influence on steroid response
117169 Completed An open label positron emission tomography (PET) imaging study using 89Zirconium labeled GSK3128349 to investigate the biodistribution and clearance of an albumin binding domain antibody (AlbudAb) GSK3128349 following single dose intravenous administration in healthy male subjects
117170 Active, Not Recruiting Analysis Plan for the Integrated Analysis of Cardiovascular Risk Among Type II Diabetes Subjects Exposed to GSK716155 in the Phase III Program
117211 Completed Plan to Assess the incidence of cardiovascular related adverse events in controlled clinical trials of bupropion for the treatment of smoking cessation
117252 Completed PGx6602 Pharmacogenomics study of extreme response to metformin
117374 Active, not recruiting PGx6633: FLAIR (GSK2190915) ADME Replication, Exploring the roles of UGT1A1 and UGT1A3
200226 Completed Adjusting for treatment crossover in a Phase 2 trial of dabrafenib and trametinib combination therapy in patients with metastatic melanoma
200239 Completed Longitudinal Analysis of Efficacy and Safety of Alitretinoin in Patients with Severe Chronic Hand Eczema Refractory to Corticosteroids
200277 Active, Not Recruiting Meta-Analysis Plan for liver analyses with GW786034 (pazopanib) treatment in advanced/metastatic renal cell carcinoma and soft tissue sarcoma to support a regulatory post marketing requirement
200363 Completed An open-label study to characterize the pharmacokinetics and pharmacodynamics of mepolizumab administered subcutaneously in children from 6 to 11 years of age with severe eosinophilic asthma
200382 Completed Cost-effectiveness of combined use of ropinirole controlled-release and L-dopa compared with L-dopa monotherapy in patients with Parkinson's disease
200719 Terminated Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
200721 Terminated Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor
200791 Completed Clinical Pharmacology Reporting and Analysis Plan for a Combined Analyses to Evaluate the Effect of Ofatumumab on Cardiac Repolarization (QTc Duration)
200952 Completed A Repeat-dose Study in Subjects with Type 2 Diabetes Mellitus to Assess the Efficacy, Safety, Tolerability and Pharmacodynamics, of Albiglutide Liquid Drug Product
200977 Completed Study 200977: Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the treatment of Subjects With Type 2 Diabetes Mellitus: The Switch Study
201023 Terminated A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin (GSK1325756) co-administered with a standard-of-care antiviral (oseltamivir), in the treatment of adults hospitalized with influenza
201065 Completed PGx7558: An Exploratory Study of Genetic Effects on Anoro (GSK573719/GW642444) in Chronic Obstructive Pulmonary Disease in Multiple Clinical Studies



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.